$EXOZ News
Last published 3w ago
- 3w agoEXOZeXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower ResearchACCESS NewswireOctober 22 investor event will explore eXoZymes' commercialization, manufacturing economics, path to market launch, growth strategy, and milestones ahead. LOS ANGELES, CA / ACCESS Newswire / October 21, 2026 /
- 2mo agoEXOZeXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCTACCESS NewswireProgram expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027 Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027 LOS ANGELES,
- 2mo agoEXOZeXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET TodayACCESS NewswireManagement to host Q2 2026 update at 5PM ET / 2PM PT, today. LOS ANGELES, CA / ACCESS Newswire / August 20, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that
- 2mo agoEXOZeXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic TargetsACCESS NewswireOptimized process delivered a 10-fold improvement in productivity, significantly improving the estimated economics of future commercial-scale manufacturing.Estimated manufacturing cost equivalent has fallen more than
- 3mo agoMDBHBUDAEXOZMDB Capital Holdings Provides Second Quarter 2026 UpdateGlobeNewswireAddison, TX, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining, disruptive technology companies, provides a
- 3mo agoEXOZeXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026ACCESS NewswireToday, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced the plan to host a webinar on
- 3mo agoEXOZeXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free BiomanufacturingACCESS NewswireCompany to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins designed to accelerate optimization of enzyme-driven manufacturing processes.The 9-month project awarded approximately
- 4mo agoEXOZeXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryACCESS NewswireAward allows eXoZymes to expand its portfolio of proprietary new-to-nature molecules and potential future pharmaceutical assets and validates the Company's ability to make rare cannabinoids and new cannabinoid-like
- 4mo agoEXOZeXoZymes Inc. Announces Closing of $6 Million Public OfferingACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / June 17, 2026 / eXoZymes Inc. , a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel
- 5mo agoEXOZeXoZymes Inc. Announces Pricing of Public Offering of Common Stock and WarrantsACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / June 8, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel
- 6mo agoEXOZeXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) ProgramACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / May 7, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transform abundant feedstock into nutraceuticals, novel medicines, and valuable
- 7mo agoEXOZeXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything PodcastACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines
- 7mo agoEXOZeXoZymes Provides Fourth Quarter and Full Year 2025 UpdateACCESS NewswireManagement to Host Conference Call Today at 5:30 PM EasternLOS ANGELES, CA / ACCESS Newswire / March 31, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transforms abundant
- 7mo agoEXOZMDBHMDB Capital Holdings Provides 2025 Full Year Update and Shareholder LetterGlobeNewswireAddison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining disruptive technology companies, today reported
- 7mo agoEXOZeXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026ACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines
- 7mo agoEXOZSuccessful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and ScalabilityACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines
- 8mo agoEXOZeXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA SymposiumACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines
- 9mo agoEXOZWith Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value CreationACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes transforming abundant feedstock into valuable nutraceuticals and new
- 9mo agoEXOZeXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot RunACCESS NewswireN-trans-caffeoyltyramine is an interesting naturally occurring compound that has attracted scientific attention in exploratory studies related to lipid metabolism and energy utilization pathways.The production was
- 11mo agoEXOZeXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock ConversionACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals
- 12mo agoEXOZeXoZymes Provides Third Quarter 2025 Update at 5PM EST TodayACCESS NewswireManagement to host Q3 2025 update at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. - a pioneer of AI-enhanced
- 12mo agoEXOZeXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of StaffACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals and new
- 1y agoEXOZeXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM ESTACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / November 10, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals,
- 1y agoEXOZCEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment ConferenceACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals,
- 1y agoEXOZCEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor ConferenceACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / October 29, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals,
- 1y agoEXOZCEO of eXoZymes to Present at ThinkEquity's Annual Investor ConferenceACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals,
- 1y agoEXOZDriving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical CommitteesACCESS NewswireLOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into
- 1y agoEXOZeXoZymes Provides Second Quarter 2025 Update at 5PM EST TodayACCESS NewswireManagement to host earnings call at 5:00PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes
- 1y agoEXOZeXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM ESTACCESS NewswireLOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines,
- 1y agoEXOZeXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% PurityACCESS NewswireUsing eXoZymes' AI-driven exozymes platform, NCTx has demonstrated lab scale validation with 4 grams of NCT produced at a 96% yield and with a purity higher than 99%.NCT project went from concept to gram scale production
- 1y agoEXOZeXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 MonthsACCESS NewswireN-trans-caffeoyltyramine is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial
- 1y agoEXOZeXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free BiomanufacturingACCESS NewswireMONROVIA, CA / ACCESS Newswire / June 26, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and
- 1y agoEXOZeXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything PodcastACCESS NewswireMONROVIA, CALIFORNIA / ACCESS Newswire / May 16, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals,
- 1y agoEXOZeXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST TodayACCESS NewswireManagement to host earnings call at 5:00PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. - a pioneer of AI-engineered enzymes that can
- 1y agoEXOZeXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM ESTACCESS NewswireMONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other
- 1y agoEXOZeXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver HealthACCESS NewswireN-trans-caffeoyltyramine is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and
- 1y agoEXOZBringing clarity and precision to the cell-free space by introducing exozymesGlobeNewswireScientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes' to bring clarity to the rapidly evolving field
- 1y agoEXOZBioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grantGlobeNewswireMonrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other
- 1y agoEXOZeXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOGlobeNewswireExpanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing
- 1y agoEXOZeXoZymes Provides Fourth Quarter and Full Year 2024 UpdateGlobeNewswireManagement to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform
- 1y agoEXOZeXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025GlobeNewswireMonrovia, CA , March 26, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels
- 1y agoEXOZMDBHeXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.GlobeNewswireMonrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ:EXOZ, formerly Invizyne Technologies)) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals,
- 1y agoEXOZMDBHeXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public OfferingGlobeNewswireMonrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (NASDAQ:EXOZ) ("eXoZymes") – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels